Market Research

Global Ocular Trauma Devices Market Size, Share & Industry Trends Analysis Report By End-Use, By Type (Implants, Instruments, and Disposables), By Indication (Blunt Trauma, Chemical Trauma, and Sharp Trauma), By Regional Outlook and Forecast, 2022 - 2028

Best Price Guarantee Length Publisher Published Date SKU
from $3,600 199 Pages Knowledge Based Value (KBV) Research November, 2022 KBV17583065
Best Price Guarantee
Price from $3,600
Length 199 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date November, 2022
SKU KBV17583065

Global Ocular Trauma Devices Market Size, Share & Industry Trends Analysis Report By End-Use, By Type (Implants, Instruments, and Disposables), By Indication (Blunt Trauma, Chemical Trauma, and Sharp Trauma), By Regional Outlook and Forecast, 2022 - 2028

The Global Ocular Trauma Devices Market size is expected to reach $5.3 billion by 2028, rising at a market growth of 6.7% CAGR during the forecast period.

Ocular trauma devices are equipment utilized in the management of ocular trauma that is caused by injuries to the area around the eyes including the eyes and eyelids. Ocular trauma is a common yet highly under-recognized cause of loss of vision. Most ocular trauma when left untreated can cause loss of vision through glaucoma or cataract.

Proper knowledge of the cause of ocular trauma followed by treatment can significantly lessen the preventable burden of it for both, ocular trauma victims and society, at large. The most common causes of ocular injuries generally include punches and blows either from any object or hands, flying shards of materials from industrial work or explosions, and other flying objects.

Some uncommon causes may include injuries caused by chemical splashes or during protests, riots, or warfare as well. The common symptoms of ocular injuries are torn or cut eyelids, hindrance in the proper working of the eye, or eyes sticking out of the socket. Since a specified description of ocular trauma does not exist, based on the institutions, ocular injuries and their symptoms can be described more inclusively.

It has been witnessed that about 20 to 25% of patients sustaining facial fractures have ocular or orbital injuries, and out of these, 80% of them most probably will have ocular trauma. Ocular trauma-induced vision loss is generally described as the best corrected visual acquits that is less than 20/40. It can also be defined as visual field defects, visually significant scotomas, or loss of contrast sensitivity.

COVID-19 Impact

There were consequently fewer elective eye surgeries carried out in hospital and clinical settings. The prohibition of trade with foreign nations and the implementation of travel restrictions led to a decline in eye diagnoses as well. Throughout the world, only emergency referrals from other health institutions, some outpatient crises, and inpatients with severe medical conditions that necessitated keeping them hospitalized were addressed by hospitals during the COVID-19 pandemic. All these factors, consequently hindered the supply chain of ocular trauma devices, along with the decreasing demand for them. Therefore, the pandemic had a negative impact on the ocular trauma devices market.

Market Growth Factors

Increasing Adoption Of Microsurgeries And Technological Advancements

Precision has become a requirement in the healthcare industry owing to rising technological advancement and the adoption of microsurgeries. Specifically, the growing number of individuals opting for ophthalmic microsurgeries has increased the demand for ophthalmic devices and instruments. Major participants in the industry are trying to meet these demands by developing innovative products that would assist in the diagnosis of ocular disorders.

Increasing Prevalence And Awareness Of Eye Disorders

Blindness and vision impairment have an impact on people's lives everywhere. Since there are fewer options to get the necessary eye care services, the burden of visual impairment can be considerably larger among low- and middle-income families in developing nations. This has motivated many governments to actively promote awareness campaigns regarding preventive blindness and vision impairment. Consequently, this has promoted the adoption of eye care and increased the number of patients visiting eye clinics.

Market Restraining Factors

Strict Product Approval Regulations

While there is a growing demand for ocular trauma devices, the introduction of subpar products has raised more precautions than cures. This has led the authorities in developed nations to attentively assess ophthalmic devices and equipment offering services. In most cases, these strict assessments have asked for the retrieval of products by the manufacturers. For example, a major manufacturer of ophthalmic devices, Alcon had to willingly recall the CyPass Micro-Stent device from all markets as the incidence of this device causing endothelial loss was discovered.

Type Outlook

Based on type, the ocular trauma devices market is categorized into implants, instruments, and disposables. The instruments segment garnered a substantial revenue share in the ocular trauma devices market in 2021. Common instruments employed in the surgeries and treatment of eye injuries include clamps, needle guides, and squint hooks. A device known as a muscle clamp, which is made of combining squint hooks, is highly preferred by ophthalmologists as it allows the simplification of operations.

Indication Outlook

On the basis of indication, the ocular trauma devices market is divided into blunt trauma, chemical trauma, and sharp trauma. The sharp trauma segment procured a considerable revenue share in the ocular trauma devices market in 2021. The most significant factor behind the growth of the segment is eye injuries that occurred during work. Many workplace injuries are caused by sharp objects, falls, trips, or contact with sharp equipment and items.

End-Use Outlook

Based on end-use, the ocular trauma devices market is segmented into hospitals, ophthalmic clinics, and others. The hospital segment witnessed the maximum revenue share in the ocular trauma devices market in 2021. The facility of efficient and affordable treatments in the hospitals along with the advancement in ophthalmic technology is accountable for the growth of the segment. Since the number of patients suffering from ocular injuries is increasing, hospitals are using newer devices and instruments, which is benefitting the market.

Regional Outlook

On the basis of region, the ocular trauma devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the largest revenue share in the ocular trauma devices market in 2021. In the region, a general increase in chronic eye disorders has been observed which are caused by poor or nutrition-deficient foods and high levels of stress. The prominent growth in the aging population, the growing number of patients suffering from eye disorders, growing expenditure on healthcare have increased the number of people needing surgeries significantly. These factors have fastened the growth of the segment.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Glaukos Corporation, Alcon, Inc., EssilorLuxottica SA (Essilor Instruments USA), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Carl Zeiss AG, Topcon Corporation, CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Hoya Corporation.

Scope of the Study

Market Segments covered in the Report:

By End-Use

  • Hospitals
  • Ophthalmic Clinics
  • Others
By Type
  • Implants
  • Instruments
  • Disposables
By Indication
  • Blunt Trauma
  • Chemical Trauma
  • Sharp Trauma
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
  • Glaukos Corporation
  • Alcon, Inc.
  • EssilorLuxottica SA (Essilor Instruments USA)
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Carl Zeiss AG
  • Topcon Corporation
  • CooperVision, Inc. (THE COOPER COMPANIES, INC.)
  • Hoya Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Ocular Trauma Devices Market, by End-Use
1.4.2 Global Ocular Trauma Devices Market, by Type
1.4.3 Global Ocular Trauma Devices Market, by Indication
1.4.4 Global Ocular Trauma Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Ocular Trauma Devices Market by End-Use
3.1 Global Hospitals Market by Region
3.2 Global Ophthalmic Clinics Market by Region
3.3 Global Others Market by Region
Chapter 4. Global Ocular Trauma Devices Market by Type
4.1 Global Implants Market by Region
4.2 Global Instruments Market by Region
4.3 Global Disposables Market by Region
Chapter 5. Global Ocular Trauma Devices Market by Indication
5.1 Global Blunt Trauma Market by Region
5.2 Global Chemical Trauma Market by Region
5.3 Global Sharp Trauma Market by Region
Chapter 6. Global Ocular Trauma Devices Market by Region
6.1 North America Ocular Trauma Devices Market
6.1.1 North America Ocular Trauma Devices Market by End-Use
6.1.1.1 North America Hospitals Market by Country
6.1.1.2 North America Ophthalmic Clinics Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Ocular Trauma Devices Market by Type
6.1.2.1 North America Implants Market by Country
6.1.2.2 North America Instruments Market by Country
6.1.2.3 North America Disposables Market by Country
6.1.3 North America Ocular Trauma Devices Market by Indication
6.1.3.1 North America Blunt Trauma Market by Country
6.1.3.2 North America Chemical Trauma Market by Country
6.1.3.3 North America Sharp Trauma Market by Country
6.1.4 North America Ocular Trauma Devices Market by Country
6.1.4.1 US Ocular Trauma Devices Market
6.1.4.1.1 US Ocular Trauma Devices Market by End-Use
6.1.4.1.2 US Ocular Trauma Devices Market by Type
6.1.4.1.3 US Ocular Trauma Devices Market by Indication
6.1.4.2 Canada Ocular Trauma Devices Market
6.1.4.2.1 Canada Ocular Trauma Devices Market by End-Use
6.1.4.2.2 Canada Ocular Trauma Devices Market by Type
6.1.4.2.3 Canada Ocular Trauma Devices Market by Indication
6.1.4.3 Mexico Ocular Trauma Devices Market
6.1.4.3.1 Mexico Ocular Trauma Devices Market by End-Use
6.1.4.3.2 Mexico Ocular Trauma Devices Market by Type
6.1.4.3.3 Mexico Ocular Trauma Devices Market by Indication
6.1.4.4 Rest of North America Ocular Trauma Devices Market
6.1.4.4.1 Rest of North America Ocular Trauma Devices Market by End-Use
6.1.4.4.2 Rest of North America Ocular Trauma Devices Market by Type
6.1.4.4.3 Rest of North America Ocular Trauma Devices Market by Indication
6.2 Europe Ocular Trauma Devices Market
6.2.1 Europe Ocular Trauma Devices Market by End-Use
6.2.1.1 Europe Hospitals Market by Country
6.2.1.2 Europe Ophthalmic Clinics Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Ocular Trauma Devices Market by Type
6.2.2.1 Europe Implants Market by Country
6.2.2.2 Europe Instruments Market by Country
6.2.2.3 Europe Disposables Market by Country
6.2.3 Europe Ocular Trauma Devices Market by Indication
6.2.3.1 Europe Blunt Trauma Market by Country
6.2.3.2 Europe Chemical Trauma Market by Country
6.2.3.3 Europe Sharp Trauma Market by Country
6.2.4 Europe Ocular Trauma Devices Market by Country
6.2.4.1 Germany Ocular Trauma Devices Market
6.2.4.1.1 Germany Ocular Trauma Devices Market by End-Use
6.2.4.1.2 Germany Ocular Trauma Devices Market by Type
6.2.4.1.3 Germany Ocular Trauma Devices Market by Indication
6.2.4.2 UK Ocular Trauma Devices Market
6.2.4.2.1 UK Ocular Trauma Devices Market by End-Use
6.2.4.2.2 UK Ocular Trauma Devices Market by Type
6.2.4.2.3 UK Ocular Trauma Devices Market by Indication
6.2.4.3 France Ocular Trauma Devices Market
6.2.4.3.1 France Ocular Trauma Devices Market by End-Use
6.2.4.3.2 France Ocular Trauma Devices Market by Type
6.2.4.3.3 France Ocular Trauma Devices Market by Indication
6.2.4.4 Russia Ocular Trauma Devices Market
6.2.4.4.1 Russia Ocular Trauma Devices Market by End-Use
6.2.4.4.2 Russia Ocular Trauma Devices Market by Type
6.2.4.4.3 Russia Ocular Trauma Devices Market by Indication
6.2.4.5 Spain Ocular Trauma Devices Market
6.2.4.5.1 Spain Ocular Trauma Devices Market by End-Use
6.2.4.5.2 Spain Ocular Trauma Devices Market by Type
6.2.4.5.3 Spain Ocular Trauma Devices Market by Indication
6.2.4.6 Italy Ocular Trauma Devices Market
6.2.4.6.1 Italy Ocular Trauma Devices Market by End-Use
6.2.4.6.2 Italy Ocular Trauma Devices Market by Type
6.2.4.6.3 Italy Ocular Trauma Devices Market by Indication
6.2.4.7 Rest of Europe Ocular Trauma Devices Market
6.2.4.7.1 Rest of Europe Ocular Trauma Devices Market by End-Use
6.2.4.7.2 Rest of Europe Ocular Trauma Devices Market by Type
6.2.4.7.3 Rest of Europe Ocular Trauma Devices Market by Indication
6.3 Asia Pacific Ocular Trauma Devices Market
6.3.1 Asia Pacific Ocular Trauma Devices Market by End-Use
6.3.1.1 Asia Pacific Hospitals Market by Country
6.3.1.2 Asia Pacific Ophthalmic Clinics Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Ocular Trauma Devices Market by Type
6.3.2.1 Asia Pacific Implants Market by Country
6.3.2.2 Asia Pacific Instruments Market by Country
6.3.2.3 Asia Pacific Disposables Market by Country
6.3.3 Asia Pacific Ocular Trauma Devices Market by Indication
6.3.3.1 Asia Pacific Blunt Trauma Market by Country
6.3.3.2 Asia Pacific Chemical Trauma Market by Country
6.3.3.3 Asia Pacific Sharp Trauma Market by Country
6.3.4 Asia Pacific Ocular Trauma Devices Market by Country
6.3.4.1 China Ocular Trauma Devices Market
6.3.4.1.1 China Ocular Trauma Devices Market by End-Use
6.3.4.1.2 China Ocular Trauma Devices Market by Type
6.3.4.1.3 China Ocular Trauma Devices Market by Indication
6.3.4.2 Japan Ocular Trauma Devices Market
6.3.4.2.1 Japan Ocular Trauma Devices Market by End-Use
6.3.4.2.2 Japan Ocular Trauma Devices Market by Type
6.3.4.2.3 Japan Ocular Trauma Devices Market by Indication
6.3.4.3 India Ocular Trauma Devices Market
6.3.4.3.1 India Ocular Trauma Devices Market by End-Use
6.3.4.3.2 India Ocular Trauma Devices Market by Type
6.3.4.3.3 India Ocular Trauma Devices Market by Indication
6.3.4.4 South Korea Ocular Trauma Devices Market
6.3.4.4.1 South Korea Ocular Trauma Devices Market by End-Use
6.3.4.4.2 South Korea Ocular Trauma Devices Market by Type
6.3.4.4.3 South Korea Ocular Trauma Devices Market by Indication
6.3.4.5 Singapore Ocular Trauma Devices Market
6.3.4.5.1 Singapore Ocular Trauma Devices Market by End-Use
6.3.4.5.2 Singapore Ocular Trauma Devices Market by Type
6.3.4.5.3 Singapore Ocular Trauma Devices Market by Indication
6.3.4.6 Malaysia Ocular Trauma Devices Market
6.3.4.6.1 Malaysia Ocular Trauma Devices Market by End-Use
6.3.4.6.2 Malaysia Ocular Trauma Devices Market by Type
6.3.4.6.3 Malaysia Ocular Trauma Devices Market by Indication
6.3.4.7 Rest of Asia Pacific Ocular Trauma Devices Market
6.3.4.7.1 Rest of Asia Pacific Ocular Trauma Devices Market by End-Use
6.3.4.7.2 Rest of Asia Pacific Ocular Trauma Devices Market by Type
6.3.4.7.3 Rest of Asia Pacific Ocular Trauma Devices Market by Indication
6.4 LAMEA Ocular Trauma Devices Market
6.4.1 LAMEA Ocular Trauma Devices Market by End-Use
6.4.1.1 LAMEA Hospitals Market by Country
6.4.1.2 LAMEA Ophthalmic Clinics Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Ocular Trauma Devices Market by Type
6.4.2.1 LAMEA Implants Market by Country
6.4.2.2 LAMEA Instruments Market by Country
6.4.2.3 LAMEA Disposables Market by Country
6.4.3 LAMEA Ocular Trauma Devices Market by Indication
6.4.3.1 LAMEA Blunt Trauma Market by Country
6.4.3.2 LAMEA Chemical Trauma Market by Country
6.4.3.3 LAMEA Sharp Trauma Market by Country
6.4.4 LAMEA Ocular Trauma Devices Market by Country
6.4.4.1 Brazil Ocular Trauma Devices Market
6.4.4.1.1 Brazil Ocular Trauma Devices Market by End-Use
6.4.4.1.2 Brazil Ocular Trauma Devices Market by Type
6.4.4.1.3 Brazil Ocular Trauma Devices Market by Indication
6.4.4.2 Argentina Ocular Trauma Devices Market
6.4.4.2.1 Argentina Ocular Trauma Devices Market by End-Use
6.4.4.2.2 Argentina Ocular Trauma Devices Market by Type
6.4.4.2.3 Argentina Ocular Trauma Devices Market by Indication
6.4.4.3 UAE Ocular Trauma Devices Market
6.4.4.3.1 UAE Ocular Trauma Devices Market by End-Use
6.4.4.3.2 UAE Ocular Trauma Devices Market by Type
6.4.4.3.3 UAE Ocular Trauma Devices Market by Indication
6.4.4.4 Saudi Arabia Ocular Trauma Devices Market
6.4.4.4.1 Saudi Arabia Ocular Trauma Devices Market by End-Use
6.4.4.4.2 Saudi Arabia Ocular Trauma Devices Market by Type
6.4.4.4.3 Saudi Arabia Ocular Trauma Devices Market by Indication
6.4.4.5 South Africa Ocular Trauma Devices Market
6.4.4.5.1 South Africa Ocular Trauma Devices Market by End-Use
6.4.4.5.2 South Africa Ocular Trauma Devices Market by Type
6.4.4.5.3 South Africa Ocular Trauma Devices Market by Indication
6.4.4.6 Nigeria Ocular Trauma Devices Market
6.4.4.6.1 Nigeria Ocular Trauma Devices Market by End-Use
6.4.4.6.2 Nigeria Ocular Trauma Devices Market by Type
6.4.4.6.3 Nigeria Ocular Trauma Devices Market by Indication
6.4.4.7 Rest of LAMEA Ocular Trauma Devices Market
6.4.4.7.1 Rest of LAMEA Ocular Trauma Devices Market by End-Use
6.4.4.7.2 Rest of LAMEA Ocular Trauma Devices Market by Type
6.4.4.7.3 Rest of LAMEA Ocular Trauma Devices Market by Indication
Chapter 7. Company Profiles
7.1 Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals and Trials:
7.1.6 SWOT Analysis
7.2 Glaukos Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Alcon, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.3.5.2 Acquisition and Mergers:
7.4 EssilorLuxottica SA (Essilor Instruments USA)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Carl Zeiss AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Topcon Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 CooperVision, Inc. (THE COOPER COMPANIES, INC.)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Hoya Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses

$3,600
$4,320
$6,048

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings